Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Discovery Lab: USPTO Issues New Patent Supporting AEROSURF Development Program

RELATED NEWS
Trade DSCO now with 

Discovery Laboratories, Inc. (DSCO: Quote), a specialty biotechnology company, announced the United States Patent and Trademark Office, or USPTO, has issued a Notice of Allowance for a patent entitled "Capillary System With Fluidic Element." The license to this patent will provide the company with additional exclusivity regarding certain proprietary and technical aspects of its capillary aerosol generator technology, a key component of its AEROSURF program.

AEROSURF is an investigational combination drug-device product being developed to deliver Discovery Labs' KL4 surfactant in aerosolized form to premature infants with respiratory distress syndrome. The company plans to initiate its AEROSURF phase 2 clinical program in the fourth quarter of 2013.

Click here to receive FREE breaking news email alerts for Discovery Laboratories Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.